A carregar...
Targeted Therapy for Hepatocellular Carcinoma: Co-Delivery of Sorafenib and Curcumin Using Lactosylated pH-Responsive Nanoparticles
PURPOSE: Hepatocellular carcinoma (HCC) is a leading cancer worldwide. In the present investigation, sorafenib (SFN) and curcumin (CCM) were co-delivered using pH-sensitive lactosylated nanoparticles (LAC-NPs) for targeted HCC treatment. METHODS: pH-responsive lactosylated materials were synthesized...
Na minha lista:
| Publicado no: | Drug Des Devel Ther |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7035906/ https://ncbi.nlm.nih.gov/pubmed/32109990 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S238955 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|